These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 29433454)

  • 1. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
    Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
    BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update.
    Han R; Zhou J; François C; Toumi M
    BMC Infect Dis; 2019 Jul; 19(1):655. PubMed ID: 31337339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review.
    Mason LM; Duffell E; Veldhuijzen IK; Petriti U; Bunge EM; Tavoschi L
    Euro Surveill; 2019 Jul; 24(30):. PubMed ID: 31362808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study.
    Trickey A; Bivegete S; Duffell E; McNaughton AL; Nerlander L; Walker JG; Fraser H; Hickman M; Vickerman P; Brooks-Pollock E; Christensen H
    BMC Infect Dis; 2023 Jul; 23(1):457. PubMed ID: 37430220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: A systematic review.
    Davlidova S; Haley-Johnson Z; Nyhan K; Farooq A; Vermund SH; Ali S
    Int J Infect Dis; 2021 Mar; 104():510-525. PubMed ID: 33385583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.
    Bao Y; Larney S; Peacock A; Colledge S; Grebely J; Hickman M; Degenhardt L; Leung J
    Int J Drug Policy; 2019 Aug; 70():87-93. PubMed ID: 31125802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
    Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
    Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria.
    Adoga MP; Banwat EB; Forbi JC; Nimzing L; Pam CR; Gyar SD; Agabi YA; Agwale SM
    J Infect Dev Ctries; 2009 Aug; 3(7):539-47. PubMed ID: 19762972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis.
    Smith DJ; Jordan AE; Frank M; Hagan H
    BMC Infect Dis; 2016 Sep; 16(1):471. PubMed ID: 27595855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County.
    Gahrton C; Westman G; Lindahl K; Öhrn F; Dalgard O; Lidman C; Nilsson LH; Said K; Duberg AS; Aleman S
    BMC Infect Dis; 2019 Nov; 19(1):955. PubMed ID: 31706284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review.
    Bivegete S; McNaughton AL; Trickey A; Thornton Z; Scanlan B; Lim AG; Nerlander L; Fraser H; Walker JG; Hickman M; Vickerman P; Johnson H; Duffell E; Brooks-Pollock E; Christensen H
    Euro Surveill; 2023 Jul; 28(30):. PubMed ID: 37498533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBV and HCV serological monitoring among injection drugs users in opiate substitution treatment in Bosnia and Herzegovina.
    Skocibusic S; Martinac M; Arapovic J; Grgic S; Nikolic J; Hasanagic D; Bevanda M; Ravlija J
    J Infect Dev Ctries; 2016 Sep; 10(9):968-972. PubMed ID: 27694729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
    Hahné SJ; Veldhuijzen IK; Wiessing L; Lim TA; Salminen M; Laar Mv
    BMC Infect Dis; 2013 Apr; 13():181. PubMed ID: 23597411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis.
    Syangbo A; Hickman M; Colledge-Frisby S; Leung J; Grebely J; Larney S; Degenhardt L; Trickey A
    Drug Alcohol Rev; 2023 Mar; 42(3):569-581. PubMed ID: 36600489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.
    Ray Saraswati L; Sarna A; Sebastian MP; Sharma V; Madan I; Thior I; Pulerwitz J; Tun W
    BMC Public Health; 2015 Jul; 15():726. PubMed ID: 26223866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of hepatitis B, C and D in Malawi: systematic review.
    Stockdale AJ; Mitambo C; Everett D; Geretti AM; Gordon MA
    BMC Infect Dis; 2018 Oct; 18(1):516. PubMed ID: 30314448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    Solomon SS; McFall AM; Lucas GM; Srikrishnan AK; Kumar MS; Anand S; Quinn TC; Celentano DD; Mehta SH
    PLoS Med; 2017 Nov; 14(11):e1002460. PubMed ID: 29182638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.